Chinese clinical oncology

Chinese Clinical Oncology describes itself as an open access, peer-reviewed bimonthly journal (quarterly from September 2012 to December 2015) that publishes original articles, editorials, case reports and reviews. Its stated focus is new findings in oncology and practical information on diagnosis, prevention and clinical investigation of cancer, with areas of interest including multimodality therapy, markers, imaging, tumour biology, pathology, chemoprevention and technical advances. The journal is the official journal of the Society for Translational Medicine and is published by AME Publishing Company with support from Wolters Kluwer, whose Lippincott and Ovid platforms carry the content. It is a member of COPE and follows ICMJE recommendations, and charges an article processing fee. NLM records the title as beginning in 2012, published in Hong Kong, and indexed in MEDLINE and PubMed (the journal says since 2014). It is not listed in DOAJ.